Voglibose IP 0.2 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg (In extended release form)
153.0 आईएनआर/Strip
उत्पाद विवरण:
- घुलनशीलता water
- आण्विक सूत्र C20H13NO4
- दिखावट Yellow, round, film-coated tablets
- पवित्रता 98%
- सामग्रियां
- फ़ीचर Anti-diabetic medication
- शेल्फ लाइफ वर्ष
- अधिक देखने के लिए क्लिक करें
X
मूल्य और मात्रा
- 100
उत्पाद की विशेषताएं
- C20H13NO4
- water
- Yellow, round, film-coated tablets
- वर्ष
- 98%
- Anti-diabetic medication
व्यापार सूचना
- प्रति महीने
- दिन
उत्पाद वर्णन
Description
- Each uncoated bilayered tablet contains : Voglibose IP 0.2 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg (In extended release form)
Doses
- As Directed by Physician
Indication
- Treatment of type 2 diabetes mellitus, which occurs when the level of glucose (sugar) in the blood becomes higher than normal.
- Glimepiride is an Oral diabetes medicine that helps control blood sugar levels.Voglibose is an alpha-glucosidase inhibitor which reduces intestinal absorption of starch, dextrin, and disaccharides by inhibiting the action of -glucosidase in the intestinal brush border. Inhibition of this enzyme halts the decomposition of disaccharides into.
Comprehensive Glycemic Control
The combination of Voglibose, Glimepiride, and Metformin Hydrochloride targets different pathways in glucose metabolism, facilitating robust management of blood sugar levels. This multifaceted approach benefits individuals needing maximum therapeutic support.
Quality and Stability Assured
With a purity of 98% and a two-year shelf life, these anti-diabetic tablets are developed under strict manufacturing protocols, ensuring consistent efficiency and safety. Their stability and water solubility support ease of use and long-term effectiveness.
Accessible Across India
Distributed and supplied by multiple industry professionals-including manufacturers, wholesalers, and retailers-this medication is readily available throughout India. Its accessibility ensures that patients and healthcare providers can acquire it conveniently.
FAQ's of Voglibose IP 0.2 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg (In extended release form):
Q: How should Voglibose, Glimepiride, and Metformin Hydrochloride tablets be used for diabetes management?
A: These tablets are taken orally, usually once daily or as directed by a healthcare provider. It is important to follow the prescribed dosage to achieve optimal blood sugar control and minimize potential side effects.Q: What are the main benefits of taking this combination anti-diabetic medication?
A: The synergistic combination helps regulate insulin release, decrease hepatic glucose output, and delay carbohydrate absorption, resulting in improved blood glucose control for individuals with type 2 diabetes.Q: When is it advisable to take these tablets for maximum effectiveness?
A: It is generally recommended to take the medication with meals to maximize absorption and minimize gastrointestinal discomfort caused by metformin. Always follow your doctor's timing instructions.Q: Where should I store the Voglibose, Glimepiride, and Metformin tablets?
A: The tablets should be stored in a cool, dry place away from excessive moisture and direct sunlight to maintain their potency and stability throughout the 2-year shelf life.Q: What is the appearance and distinguishing feature of this medication?
A: Each dose comprises yellow, round, film-coated tablets that are easy to identify and handle. The main distinguishing feature is its formulation as a combination anti-diabetic medication with extended-release metformin.Q: What is the suggested process for obtaining this product in India?
A: You can purchase or order these tablets through authorized dealers, distributors, suppliers, or retailers. Both private clinics and public hospitals in India may recommend this medication as part of diabetes management.Q: How does the high purity and water solubility of the tablets benefit patients?
A: With 98% purity and solubility in water, the tablets offer reliable dissolution, consistent absorption, and high therapeutic efficiency-contributing to effective and safe diabetes management.Tell us about your requirement
Price: Â
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
मोबाइल number
Email
मधुमेह विरोधी दवा अन्य उत्पाद
संपर्क करें
- बी नंबर 673, ब्लॉक-ई-673, डीएसआईआईडीसी, औद्योगिक क्षेत्र, नरेला,दिल्ली - 110040, भारत
- फ़ोन : +917971671193 PIN:( 207 )
देखभाल सूत्रीकरण लैब्स प्राइवेट लिमिटेड
GST : 07AAECC3106E1Z9
- श्री नवीन कुमार जिंदल (निदेशक)
- मोबाइल : 917971671193 PIN:( 207 )
- जांच भेजें
- Mr. Naveen Kumar Jindal (Director)
मोबाइल : +917827946686, +919810255103
जांच भेजें हमारे उत्पाद
- हर्बल उत्पाद
- यूरोलॉजी और नेफ्रोलॉजी चिकित्सा
- स्तंभन दोष की दवा
- फार्मास्युटिकल इंजेक्शन
- एंडोक्रिनोलॉजी टैबलेट
- ऑन्कोलॉजी चिकित्सा
- नेत्र चिकित्सा
- स्त्री रोग चिकित्सा
- दर्द निवारक दवा
- एचआईवी और एड्स की दवा
- सामान्य दवा
- संक्रमण रोधी दवा
- प्रसाधन उत्पाद
- मधुमेह विरोधी दवा
- श्वसन औषधि
- कार्डिक केयर मेडिसिन
- आयुर्वेदिक उत्पाद
- तंत्रिका संबंधी चिकित्सा
- एंटी एलर्जिक दवा
- त्वचा विज्ञान चिकित्सा
- आर्थोपेडिक चिकित्सा
- गैस्ट्रोएंटेरोलॉजिकल मेडिसिन
- शाकाहारी धुलाई
|
जांच भेजें
CARE FORMULATION LABS PRIVATE LIMITED
सर्वाधिकार सुरक्षित.(उपयोग की शर्तें)
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
इन्फोकॉम नेटवर्क प्राइवेट लिमिटेड . द्वारा विकसित एवं प्रबंधित
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese